» Articles » PMID: 24141617

Relationship Between Genetic Mutation Variations and Acute-phase Reactants in the Attack-free Period of Children Diagnosed with Familial Mediterranean Fever

Overview
Date 2013 Oct 22
PMID 24141617
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Familial Mediterranean fever (FMF) is a periodic autoinflammatory disease characterized by chronic inflammation. This study investigated the relationship between acute-phase reactants and gene mutations in attack-free periods of childhood FMF. Patients diagnosed with FMF were divided into four groups based on genetic features: no mutation, homozygous, heterozygous, and compound heterozygous. These groups were monitored for 2 years, and blood samples were collected every 6 months during attack-free periods. Erythrocyte sedimentation rate, C-reactive protein, fibrinogen, and white blood cell count were measured. A disease severity score was determined for each patient. Mean values for erythrocyte sedimentation rate and fibrinogen were significantly different in the homozygous group. White blood cell count and C-reactive protein were similar between the groups. Disease severity score was higher in patients with the M694V mutation than in individuals without the mutation, as well as in those with other mutation groups. Periodic follow-up of patients with FMF MEFV mutations in subjects with acute-phase reactants may be useful in the prevention of morbidity.

Citing Articles

The Impact of Gene Variants on Acute-Phase Reactants in Children with Rheumatic Heart Disease.

Almazroea A, Yousef S, Ahmad S, AlHiraky H, Al-Haidose A, Abdallah A Diagnostics (Basel). 2023; 13(10).

PMID: 37238156 PMC: 10217348. DOI: 10.3390/diagnostics13101672.


[Role of genetics in familial Mediterranean fever].

Kallinich T, Orak B, Wittkowski H Z Rheumatol. 2017; 76(4):303-312.

PMID: 28154935 DOI: 10.1007/s00393-017-0265-9.


Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever.

Kilic A, Varkal M, Durmus M, Yildiz I, Yildirim Z, Turunc G Pediatr Rheumatol Online J. 2016; 13:59.

PMID: 26759267 PMC: 4711108. DOI: 10.1186/s12969-015-0057-1.

References
1.
Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L . Does immune activation continue during an attack-free period in familial Mediterranean fever?. Clin Exp Immunol. 2004; 138(3):526-33. PMC: 1809227. DOI: 10.1111/j.1365-2249.2004.02632.x. View

2.
Erguven M, Emeksiz C, Deveci M, Ozlu S . Relation between microalbuminuria and gene mutations in familial Mediterranean fever. Turk J Pediatr. 2008; 50(4):326-30. View

3.
Tunca M, Kirkali G, Soyturk M, Akar S, Pepys M, Hawkins P . Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999; 353(9162):1415. DOI: 10.1016/S0140-6736(99)00990-3. View

4.
Bakkaloglu A . Familial Mediterranean fever. Pediatr Nephrol. 2003; 18(9):853-9. DOI: 10.1007/s00467-003-1185-2. View

5.
Padeh S, Shinar Y, Pras E, Zemer D, Langevitz P, Pras M . Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol. 2003; 30(1):185-90. View